A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2009
12/17/2009	US20090312394 Protection against and treatment of age related macular degeneration
12/17/2009	US20090312393 Cancer therapy using bcl-xl-specific sina
12/17/2009	US20090312392 Amino ceramide-like compounds and therapeutic methods of use
12/17/2009	US20090312391 Unifying mechanism and methods to prevent cancer and neurodegenerative diseases
12/17/2009	US20090312390 Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma
12/17/2009	US20090312389 Azabicylic compounds, a process for their preparation and pharmaceutical compositions containing them
12/17/2009	US20090312388 Benzo [F] Isoindoles As EP4 Receptor Agonists
12/17/2009	US20090312387 Composition for controlling parasites on animals
12/17/2009	US20090312386 Novel crystals of substituted phenylalkanoic acid and method of producing the same
12/17/2009	US20090312385 Cannabinoid receptor modulators for treating non-immediate type allergic diseases
12/17/2009	US20090312384 Benzimidazole As Cooling Compounds
12/17/2009	US20090312383 Fused Heterocyclic Compounds
12/17/2009	US20090312382 Novel imidazolidine derivatives
12/17/2009	US20090312381 Substituted Arylimidazolone and Triazolone as Inhibitors of Vasopressin Receptors
12/17/2009	US20090312380 Novel compositions and methods
12/17/2009	US20090312379 Dimeric Small Molecule Potentiators of Apoptosis
12/17/2009	US20090312377 Derivatives of benzo[d]isothiazoles as histones deacetylase inhibitors
12/17/2009	US20090312376 5-(4-methanesulfonyl-phenyl)-thiazole derivatives for the treatment of acute and chronic inflammatory diseases
12/17/2009	US20090312375 Heterocyclic compounds, compositions comprising them and methods of their use
12/17/2009	US20090312374 Derivatives of 4,6-disubstituted 1,2,4-triazolo- 1,3,4-thiadiazole, a process and uses thereof
12/17/2009	US20090312373 Methods for the treatment of cancer using piperlongumine and piperlongumine analogs
12/17/2009	US20090312372 Chemical compounds
12/17/2009	US20090312371 Substituted arylpyrazoles
12/17/2009	US20090312370 Macrocyclic compounds useful as bace inhibitors
12/17/2009	US20090312369 Renin Inhibitors
12/17/2009	US20090312368 Pyridine Analogues IV
12/17/2009	US20090312367 Combination of modafinil and an antagonist or inverse agonist of the h3 receptor
12/17/2009	US20090312366 Novel p2x7r antagonists and their use
12/17/2009	US20090312365 Certain Chemical Entities, Compositions, and Methods
12/17/2009	US20090312364 Novel chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
12/17/2009	US20090312363 Bifunctional histone deacetylase inhibitors
12/17/2009	US20090312362 Inhibitors of the unfolded protein response and methods for their use
12/17/2009	US20090312361 Novel pharmaceutical compositions for treating acquired chronic pain and associated dysphoria
12/17/2009	US20090312360 Antineoplastic Combinations Containing HKI-272 and Vinorelbine
12/17/2009	US20090312359 Use of methylnaltrexone and related compounds for treatment of gastrointestinal dysfunction induced by endogenous opioids
12/17/2009	US20090312358 Method for management of diarrhea
12/17/2009	US20090312357 Rifaximin
12/17/2009	US20090312356 Nicotinic agonists selective for the alpha7 receptor subtype, the process for the preparation thereof and pharmaceutical compositions therefrom
12/17/2009	US20090312355 Non-Flushing Niacin Analogues, and Methods of Use Thereof
12/17/2009	US20090312354 DHA Esters and Use Thereof In Treatment and Prevention of Cardiovascular Disease
12/17/2009	US20090312353 Methods and compositions for treating liquid tumors
12/17/2009	US20090312352 Compositions and methods for treatment of disease caused by yersinia spp infection
12/17/2009	US20090312351 Processes for the Preparation of Alfuzosin
12/17/2009	US20090312350 Compositions comprising balaglitazone and further antidiabetic compounds
12/17/2009	US20090312349 Anti-inflammatory medicaments
12/17/2009	US20090312348 Use of sodium blockers for an early therapy of obstructive lung diseases
12/17/2009	US20090312347 Novel oxadiazole derivatives and their medical use
12/17/2009	US20090312346 Method for increasing the bioavailability of benzhydryl piperazine containing compounds
12/17/2009	US20090312345 Pharmacological chaperones for treating obesity
12/17/2009	US20090312344 Arylpiperazine derivatives as adrenergic receptor antagonists
12/17/2009	US20090312343 Quinazoline derivatives as tyrosine kinase inhibitors
12/17/2009	US20090312342 Quinazolines useful as modulators of ion channels
12/17/2009	US20090312341 Cyclic amine bace-1 inhibitors having a heterocyclic substituent
12/17/2009	US20090312340 Use of ranolazine for the treatment of cardiovascular diseases
12/17/2009	US20090312339 Benzimidazole cannabinoid agonists bearing a substituted heterocyclic group
12/17/2009	US20090312338 Novel Tricyclic Compounds
12/17/2009	US20090312337 Compositions containing alpha-2-adrenergic agonist components
12/17/2009	US20090312336 Dihydropteridine compounds as anti proliferative agents
12/17/2009	US20090312335 Hiv Integrase Inhibitors
12/17/2009	US20090312334 Immunomodulating Heterocyclic Compounds
12/17/2009	US20090312333 2-Oxo-1-Pyrrolidine Derivatives, Processes for Preparing Them and Their Uses
12/17/2009	US20090312332 Compounds for the treatment of auricular fibrillation
12/17/2009	US20090312331 PROCESS FOR PREPARING SALTS OF 4-[[5-[(CYCLOPROPYLAMINO)CARBONYL]-2-METHYLPHENYL]AMINO]-5-METHYL-N-PROPYLPYRROLO[2,1-f][1,2,4]TRIAZINE-6-CARBOXAMIDE AND NOVEL STABLE FORMS PRODUCED THEREIN
12/17/2009	US20090312330 Isoxazoline-substituted benzamide compound and pesticide
12/17/2009	US20090312329 Cyclic hydroxylamine as psychoactive compounds
12/17/2009	US20090312328 Sulfonamide compound or salt thereof
12/17/2009	US20090312327 Pyrrolidine derivatives as nk2 receptor antagonists
12/17/2009	US20090312326 Substituted imidazoles
12/17/2009	US20090312325 Quinoline Derivatives As Phosphodiesterase Inhibitors
12/17/2009	US20090312324 Compositions and Methods Related to RAD51 Inactivation in the Treatment of Neoplastic Diseases, and Especially CML
12/17/2009	US20090312323 Compounds for the treatment of spinal muscular atrophy and other uses
12/17/2009	US20090312322 Use of Oxindole Derivatives in the Treatment of Dementia Related Diseases, Alzheimer's Disease and Conditions Associated with Glycogen Synthase Kinase-3
12/17/2009	US20090312321 Compositions and methods for fgf receptor kinases inhibitors
12/17/2009	US20090312320 Methods of treatment comprising the administration of haloaryl substituted aminopurines or compositions thereof
12/17/2009	US20090312319 Certain chemical entities, compositions and methods
12/17/2009	US20090312318 Therapeutic compounds and methods
12/17/2009	US20090312317 Coumarin compounds and their use for treating cancer
12/17/2009	US20090312316 Novel compounds
12/17/2009	US20090312315 Pai-1 inhibitor
12/17/2009	US20090312314 Heteroaromatic monoamides as orexinin receptor antagonists
12/17/2009	US20090312313 Compound having tgfbeta inhibitory activity and pharmaceutical composition comprising the same
12/17/2009	US20090312312 Heterobicyclic Metalloprotease Inhibitors
12/17/2009	US20090312311 Combination of organic compounds
12/17/2009	US20090312310 Imidazothiazole derivatives
12/17/2009	US20090312309 Novel Medicaments
12/17/2009	US20090312308 Compounds and compositions as hedgehog signaling pathway modulators
12/17/2009	US20090312307 Heterocyclo inhibitors of potassium channel function
12/17/2009	US20090312306 Tetrahydro-5h-pyrido[2,3-d]azepines as 5-ht2c ligands
12/17/2009	US20090312305 Bicyclic compounds having activity at the cxcr4 receptor
12/17/2009	US20090312304 Organic compounds
12/17/2009	US20090312303 Antidiabetic Bicyclic Compounds
12/17/2009	US20090312302 Compositions and methods for treating nonalcoholic fatty liver disease-associated disorders
12/17/2009	US20090312301 Transition Metal Complexes for Inhibiting Resistance in the Treatment of Cancer and Metastasis
12/17/2009	US20090312300 Novel macrocyclic peptides
12/17/2009	US20090312299 Isolated Isomers of Norelgestromin and Methods of Making and Using the Same
12/17/2009	US20090312298 Methods and Compositions Related to GABA Receptor Subunits
12/17/2009	US20090312297 Methods for treating hypercholesterolemia and atherosclerosis
12/17/2009	US20090312296 Active ingredient combination of a retinoid and a hormone combination with contraceptive action as medicament for treatment of skin diseases
12/17/2009	US20090312295 Second line treatment of metastatic hormone refractory prostate cancer using satraplatin
12/17/2009	US20090312294 Method and Agent for Reducing Weight, Accelerating Lipid Catabolism, and/or Restricting Calories

1 ... 2454 2455 2456 2457 2458 2459 2460 2461 2462 2463 2464 2465 2466 2467 2468 2469 2470 2471 2472 2473 2474 ... 7860